General Information of Drug Transporter (DT)
DT ID DTD0326 Transporter Info
Gene Name SLC38A1
Transporter Name Sodium-coupled neutral amino acid transporter 1
Gene ID
81539
UniProt ID
Q9H2H9
Post-Translational Modification of This DT
Overview of SLC38A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Oxidation X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

251

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A1 Asparagine 251 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

257

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A1 Asparagine 257 has the potential to affect its expression or activity.

  Unclear Residue

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Critically important for the L-glutamine transport [2]

Role of PTM

Protein Activity Modulation

Affected Drug/Substrate

L-glutamine

Results for Drug

Affecting the inward transport of l-glutamine

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-glycosylation at SLC38A1 have been reported to be critically important for L-glutamine transport.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A1 [3]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

131

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC38A1 Cystine 131 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        10 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A1 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

6

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Serine 6 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A1 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

25

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Serine 25 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A1 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

28

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Serine 28 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC38A1 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

41

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Serine 41 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC38A1 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

45

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Serine 45 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC38A1 [6] , [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

49

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Serine 49 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC38A1 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

52

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Serine 52 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC38A1 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

56

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Serine 56 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC38A1 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

377

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Serine 377 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC38A1 [14]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

425

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Serine 425 has the potential to affect its expression or activity.

  Threonine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A1 [5] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

11

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Threonine 11 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A1 [5] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

17

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Threonine 17 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A1 [5] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

32

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Threonine 32 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC38A1 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

54

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Threonine 54 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC38A1 [15]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

129

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Threonine 129 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC38A1 [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

424

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Threonine 424 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC38A1 [10] , [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

442

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Threonine 442 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC38A1 [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

450

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Threonine 450 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A1 [15]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

134

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Tyrosine 134 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A1 [14]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

438

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A1 Tyrosine 438 has the potential to affect its expression or activity.

S-nitrosylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A1 [16]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

131

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation (-SNO) at SLC38A1 Cystine 131 has the potential to affect its expression or activity.

S-palmitoylation

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A1 [17]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

288

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-palmitoylation at SLC38A1 Cystine 288 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A1 [17]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

391

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-palmitoylation at SLC38A1 Cystine 391 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A1 [18] , [19]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

60

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC38A1 Lysine 60 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A1 [18] , [19]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

178

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC38A1 Lysine 178 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A1 [18] , [19]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

384

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC38A1 Lysine 384 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC38A1 [18] , [19]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

387

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC38A1 Lysine 387 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC38A1 [18] , [19]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

448

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC38A1 Lysine 448 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S38A1_HUMAN)
2 UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. (ID: Q9H2H9)
3 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
4 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
5 An orthogonal proteomic survey uncovers novel Zika virus host factors. Nature. 2018 Sep;561(7722):253-257.
6 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
7 Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer. PLoS One. 2018 Oct 2;13(10):e0204658.
8 p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
9 CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
10 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
11 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
12 Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
13 Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
14 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
15 System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal. 2011 Mar 15;4(164):rs3.
16 Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
17 Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
18 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
19 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.